Cuntai Zhang

Dr. Cuntai Zhang


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2023 in Science China Life Sciences
Verified
Journal Article
Closed access
HBHainan Bao
Hainan Bao
JCJiani Cao
Jiani Cao
MCMengting Chen
Mengting Chen
MCMin Chen
Min Chen
WCWei Chen
Wei Chen
GLGuang-Hui Liu
Guang-Hui Liu

4 April 2020 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
JHJia-Bao Huang
Jia-Bao Huang
YCYu-Si Chen
Yu-Si Chen
HJHong-Yan Ji
Hong-Yan Ji
WXWei-Ming Xie
Wei-Ming Xie
JJJie Jiang
Jie Jiang
XQXiao-Qing Quan
Xiao-Qing Quan
Background: The importance of the lipid-related biomarkers has been implicated in the pathological process and prognosis of acute myocardial infarction (AMI). Our work was conducted to discuss and compare the predictive ability of the neutrophil to high-density lipoprotein cholesterol (HDL-C) ratio (NHR) with other existing prognostic indices, for instance, the monocyte to HDL-C ratio (MHR) and the low-density lipoprotein cholesterol (LDL-C) to HDL-C ratio (LDL-C/HDL-C) in elderly patients with AMI.Methods: Our population was 528 consecutive elderly AMI patients (65–85 years) who were enrolled from Tongji Hospital and grouped according to the cutoff points which were depicted by the receiver operating characteristic (ROC). The Kaplan-Meier curves were plotted with the survival data from the follow-up to investigate the difference between cutoff point-determined groups. Moreover, we assessed the impact of NHR, MHR, LDL-C/HDL-C on the long-term mortality and recurrent myocardial infarction (RMI) with Cox proportional hazard models.Results: Mean duration of follow-up was 673.85 ± 14.32 days (median 679.50 days). According to ROC curve analysis, NHR ≥ 5.74, MHR ≥ 0.67, LDL-C/HDL-C ≥ 3.57 were regarded as high-risk groups. Kaplan-Meier analysis resulted that the high-NHR, high-MHR and high-LDL-C/HDL-C groups presented higher mortality and RMI rate than the corresponding low-risk groups in predicting the long-term clinical outcomes (log-rank test: allP < 0.050). In multivariate analysis, compared with MHR and LDL-C/HDL-C, only NHR was still recognized as a latent predictor for long-term mortality (harzard ratio [HR]: 1.96, 95% confidence interval [CI]: 1.02 to 3.75,P = 0.044) and long-term RMI (HR: 2.23, 95% CI: 1.04 to 4.79,P = 0.040). Furthermore, the positive correlation between NHR and Gensini score (r = 0.15,P < 0.001) indicated that NHR was relevant to the severity of coronary artery to some extent.Conclusions: NHR, a novel laboratory marker, might be a predictor of the long-term clinical outcomes of elderly patients with AMI, which was superior to MHR and LDL-C/HDL-C.

18 December 2019 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
JHJiabao Huang
Jiabao Huang
QZQing Zhang
Qing Zhang
RWRunchang Wang
Runchang Wang
HJHongyan Ji
Hongyan Ji
YCYusi Chen
Yusi Chen
CZCuntai Zhang
Cuntai Zhang
BACKGROUND:We assessed the utility of the systemic immune-inflammatory index (SII) in estimating the in-hospital and long-term prognosis of elderly patients with acute myocardial infarction (AMI) who received percutaneous coronary intervention (PCI)....

24 September 2018 in Oncogene
Verified
Journal Article
Closed access
PDF file
WYWeiwei Yu
Weiwei Yu
JDJie Ding
Jie Ding
MHMaio He
Maio He
YCYuan Chen
Yuan Chen
RWRonghao Wang
Ronghao Wang
SYShuyuan Yeh
Shuyuan Yeh

3 February 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SWSiyuan Wang
Siyuan Wang
JWJiaxin Wang
Jiaxin Wang
YXYu Xia
Yu Xia
LZLe Zhang
Le Zhang
YJYueqiang Jiang
Yueqiang Jiang
CZCuntai Zhang
Cuntai Zhang
Immune checkpoint blockades have been prized in circumventing and ablating the impediments posed by immunosuppressive receptors, reaching an exciting juncture to be an innovator in anticancer therapy beyond traditional therapeutics. Thus far, approved immune checkpoint blockades have principally targeted PD-1/PD-L1 and CTLA-4 with exciting success in a plethora of tumors and yet are still trapped in dilemmas of limited response rates and adverse effects. Hence, unveiling new immunotherapeutic targets has aroused immense scientific interest in the hope of expanding the clinical application of immune checkpoint blockades to scale new heights. Human leukocyte antigen-G (HLA-G), a non-classical major histocompatibility complex (MHC) class I molecule, is enriched on various malignant cells and is involved in the hindrance of immune effector cells and the facilitation of immunosuppressive cells. HLA-G stands out as a crucial next-generation immune checkpoint showing great promise for the benefit of cancer patients. Here, we provide an overview of the current understanding of the expression pattern and immunological functions of HLA-G, as well as its interaction with well-characterized immune checkpoints. Since HLA-G can be shed from the cell surface or released by various cells as free soluble HLA-G (sHLA-G) or as part of extracellular vesicles (EVs), namely HLA-G-bearing EVs (HLA-GEV), we discuss the potential of sHLA-G and HLA-GEV as predictive biomarkers. This review also addresses the advancement of HLA-G-based therapies in preclinical and clinical settings, with a focus on their clinical application in cancer.

7 February 2023 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
JCJiajie Chen
Jiajie Chen
XCXi Chen
Xi Chen
RMRuxue Mao
Ruxue Mao
YFYu Fu
Yu Fu
QCQin Chen
Qin Chen
KZKai Zheng
Kai Zheng
Background: Hypertension, sleep disorders, and depression are highly prevalent in the elderly population and are all associated with cognitive impairment, but the role that sleep quality and depression play in the association between hypertension and cognitive impairment is unclear. The aim of this study was to investigate whether sleep quality and depression have a mediating role in the association between hypertension and cognitive impairment.Methods: A cross-sectional study was conducted to collect data from the Tongji Hospital Comprehensive Geriatric Assessment Database. Sleep quality, depression and cognitive function were measured by the Pittsburgh Sleep Quality Index (PSQI), the Geriatric Depression Scale (GDS-15) and the Mini-Mental State Examination (MMSE), respectively. Correlation analysis, regression analysis and Bootstrap analysis were used to examine correlations between key variables and mediating effects of sleep quality and depression. Adjustments for multiple comparisons were performed using Benjamini-Hochberg adjustment for multiple testing.Results: A total of 827 participants were included, hypertension was present in 68.3% of the sample. After correcting for covariates, hypertensive patients aged 65 years or older had worse cognitive function, poorer-sleep quality and higher levels of depression. Sleep quality was significantly negatively associated with depression and cognitive function, while depression was negatively associated with cognitive function. Mediation analysis revealed that hypertension can affect cognitive function in older adults through a single mediating effect of sleep quality and depression and a chain mediating effect of sleep quality and depression.Conclusion: This study found that sleep quality and depression can mediate the relationship between hypertension and cognitive function in elderly. Enhanced supervision of sleep quality and depression in elderly patients with hypertension may be beneficial in maintaining cognitive function.